PIMCO INCOME STRATEGY FD II (PFN)

US72201J1043

7.36  +0.03 (+0.41%)

Fundamental Rating

2

Taking everything into account, PFN scores 2 out of 10 in our fundamental rating. PFN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of PFN have multiple concerns. PFN has a expensive valuation and it also scores bad on growth.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

PFN had positive earnings in the past year.
PFN had a positive operating cash flow in the past year.
PFN had positive earnings in 4 of the past 5 years.
PFN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The 3 year average ROIC (5.27%) for PFN is below the current ROIC(6.41%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.19%
ROE 3.75%
ROIC 6.41%
ROA(3y)3.51%
ROA(5y)4.35%
ROE(3y)5.04%
ROE(5y)5.65%
ROIC(3y)5.27%
ROIC(5y)5.1%

1.3 Margins

In the last couple of years the Profit Margin of PFN has declined.
PFN's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of PFN has remained more or less at the same level.
Industry RankSector Rank
OM 80.49%
PM (TTM) 32.29%
GM 80.8%
OM growth 3Y-1.31%
OM growth 5Y-1.45%
PM growth 3Y-27.36%
PM growth 5Y-30.65%
GM growth 3Y-1.24%
GM growth 5Y-1.4%

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PFN has more shares outstanding
Compared to 5 years ago, PFN has more shares outstanding
Compared to 1 year ago, PFN has an improved debt to assets ratio.

2.2 Solvency

PFN has an Altman-Z score of 3.04. This indicates that PFN is financially healthy and has little risk of bankruptcy at the moment.
PFN has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
PFN has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
Although PFN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.78
Altman-Z 3.04
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.05 indicates that PFN may have some problems paying its short term obligations.
A Quick Ratio of 0.05 indicates that PFN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

More info and screens

1

3. Growth

3.1 Past

The earnings per share for PFN have decreased strongly by -82.92% in the last year.
PFN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -30.79% yearly.
PFN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.17%.
PFN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.07% yearly.
EPS 1Y (TTM)-82.92%
EPS 3Y-28.27%
EPS 5Y-30.79%
EPS Q2Q%-65.45%
Revenue 1Y (TTM)12.17%
Revenue growth 3Y8.23%
Revenue growth 5Y7.07%
Sales Q2Q%13.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.53, PFN is valued on the expensive side.
Compared to an average S&P500 Price/Earnings ratio of 27.73, PFN is valued at the same level.
Industry RankSector Rank
PE 24.53
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.19
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

PFN has a Yearly Dividend Yield of 10.73%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.24, PFN pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.73%

5.2 History

PFN has paid a dividend for at least 10 years, which is a reliable track record.
PFN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

277.40% of the earnings are spent on dividend by PFN. This is not a sustainable payout ratio.
DP277.4%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

PIMCO INCOME STRATEGY FD II

NYSE:PFN (12/20/2024, 8:04:00 PM)

7.36

+0.03 (+0.41%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-26 2024-08-26
Earnings (Next)N/A N/A
Inst Owners18.74%
Inst Owner Change-0.14%
Ins Owners0.01%
Ins Owner Change0%
Market Cap633.92M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 10.73%
Dividend Growth(5Y)N/A
DP277.4%
Div Incr Years0
Div Non Decr Years1
Ex-Date12-12 2024-12-12 (0.0718)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.53
Fwd PE N/A
P/S 8.22
P/FCF 5.19
P/OCF 5.19
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.3
EY4.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.42
FCFY19.27%
OCF(TTM)1.42
OCFY19.27%
SpS0.9
BVpS7.72
TBVpS7.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 3.75%
ROCE 9.27%
ROIC 6.41%
ROICexc 6.41%
ROICexgc 6.62%
OM 80.49%
PM (TTM) 32.29%
GM 80.8%
FCFM 158.41%
ROA(3y)3.51%
ROA(5y)4.35%
ROE(3y)5.04%
ROE(5y)5.65%
ROIC(3y)5.27%
ROIC(5y)5.1%
ROICexc(3y)5.27%
ROICexc(5y)5.1%
ROICexgc(3y)5.41%
ROICexgc(5y)5.23%
ROCE(3y)8.27%
ROCE(5y)7.73%
ROICexcg growth 3Y11.03%
ROICexcg growth 5Y6.05%
ROICexc growth 3Y10.85%
ROICexc growth 5Y5.92%
OM growth 3Y-1.31%
OM growth 5Y-1.45%
PM growth 3Y-27.36%
PM growth 5Y-30.65%
GM growth 3Y-1.24%
GM growth 5Y-1.4%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.78
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 490.62%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 3.04
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.92%
EPS 3Y-28.27%
EPS 5Y-30.79%
EPS Q2Q%-65.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.17%
Revenue growth 3Y8.23%
Revenue growth 5Y7.07%
Sales Q2Q%13.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.43%
EBIT growth 3Y6.81%
EBIT growth 5Y5.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y182.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.39%
OCF growth 3YN/A
OCF growth 5YN/A